United States · FDA National Drug Code directory

AS03

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
58160-855_16e1450f-1b3b-4cc3-8b67-b0fb63dadfd2
Product NDC
58160-855
Form
INJECTION, SOLUTION
Composition / generic term
AS03
Labeler
GlaxoSmithKline Biologicals SA
Marketing category
UNAPPROVED DRUG OTHER
Marketing start / end (source format)
20201110
Source listing expiry
20261231

Source-listed ingredients

Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.

These values do not establish equivalence or a dose recommendation.

Packages

  • 10 VIAL in 1 CARTON (58160-855-19) / 2.5 mL in 1 VIAL (58160-855-01) · 58160-855-19

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →